AMICUS THERAPEUTICS, INC. — Director's Dealing 2022

Jun 22, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMICUS THERAPEUTICS, INC. (FOLD)
CIK: 0001178879
Period of Report: 2022-06-21

Reporting Person: Campbell Bradley L (Director, Chief Operating Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-21	Common Stock	M	16410	$3.53	Acquired	706028	Direct
2022-06-21	Common Stock	S	16410	$10.00	Disposed	689618	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-06-21	Stock Options (right to buy)	$3.53	M	16410	Disposed	2023-01-28	Common Stock (16410)	Direct

Footnotes

F1: The sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.

F2: All of the options were fully vested and exercisable as of the transaction date.